PET/CT Imaging in Melanoma: Review of Current Evidence and Clinical Applications
Authors:
- Vanessa Anne Mohr-Bell GiachettiVGVanessa Anne Mohr-Bell Giachetti
- Isabela Paulino SerurISIsabela Paulino Serur
- Felipe de Galiza BarbosaFBFelipe de Galiza Barbosa
- Beatriz Mendes Awni CidaleBCBeatriz Mendes Awni Cidale
- Gabriela Franco KatzGKGabriela Franco Katz
- Rodrigo Ramella MunhozRMRodrigo Ramella Munhoz
Open Access
- 25 January 2026
- journal article
- review article
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 22 (CP)
Abstract
Melanoma is regarded as a highly aggressive skin cancer due to its potential for early metastasis and poor outcomes in advanced stages. Early detection, accurate staging, follow-up imaging, and assessment of treatment response are critical for improving survival rates in melanoma patients. Positron-emission tomography/computed tomography (PET/CT), particularly utilizing 18F-fluorodeoxyglucose (18F-FDG), has become a gold standard imaging modality in the comprehensive management of melanoma. This review critically examines the current literature on the utility of PET/CT in melanoma, focusing on its diagnostic and prognostic role, current indications and rational use. By synthesizing evidence from recent studies, this article highlights the strengths and limitations of PET/CT in clinical practice and explores future directions for research in the field.Keywords
This publication has 103 references indexed in Scilit:
- Cutaneous MelanomaJAMA, 2025
- Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021JAMA Dermatology, 2023
- Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanomaCochrane Database of Systematic Reviews, 2019
- PET/MRI: Where might it replace PET/CT?Journal of Magnetic Resonance Imaging, 2017
- Role of FDG-PET/CT in stage 1–4 malignant melanoma patientsEuropean Journal of Plastic Surgery, 2016
- Extensive screening for primary tumor is redundant in melanoma of unknown primaryJournal of Surgical Oncology, 2011
- PET and PET/CT of Malignant Melanoma2010
- Meta-analysis of the performance of 18F-FDG PET in cutaneous melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patientsAnnals of Surgical Oncology, 2002
- Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomographyCancer, 1998